Cargos activos de Alan Tyndall
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| University of Basel | Corporate Officer/Principal | 01/01/1991 | - |
| World Scleroderma Foundation | Secretario Corporativo | - | - |
| Iterata AG | Director/Miembro de la Junta | - | - |
| Fundador | - | - |
Historial de carrera de Alan Tyndall
Antiguos cargos conocidos de Alan Tyndall.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| MAGENTA THERAPEUTICS | Fundador | 17/06/2015 | - |
Formación de Alan Tyndall.
| The University of Sydney | Undergraduate Degree |
Estadísticas
Internacional
| Suiza | 4 |
| Estados Unidos | 2 |
| Japón | 2 |
Operativa
| Founder | 2 |
| Corporate Officer/Principal | 1 |
| Corporate Secretary | 1 |
Sectorial
| Consumer Services | 3 |
| Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Magenta Therapeutics, Inc. is a biotechnology company, which focuses on improving stem cell transplantation. Its platform includes MGTA-117, MGTA-145, and CD45-ADC. The company was founded by David T. Scadden, Derrick J. Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner on June 17, 2015 and is headquartered in Cambridge, MA. | Health Technology |
| World Scleroderma Foundation | |
| Iterata AG |
- Bolsa de valores
- Insiders
- Alan Tyndall
- Experiencia
